Journal article
The beta1-adrenergic receptor mediates the pharmacogenetic interaction of the ACE D allele and beta-blockers
Clinical and translational science, Vol.1(2), pp.151-154
09/2008
DOI: 10.1111/j.1752-8062.2008.00020.x
PMCID: PMC5439562
PMID: 20443839
Abstract
The role of beta-receptor selectivity for the interaction between the angiotensin-converting enzyme (ACE) insertion/deletion polymorphism and beta-blocker therapy was investigated in 479 subjects with left ventricular dysfunction. Subjects were separated into no beta-blocker, beta1 -selective, and nonselective beta-blocker treatment groups. The D allele adversely affected transplant-free survival for subjects not on beta-blockers (p= 0.004). Treatment with selective beta1-blockers eliminated the impact of the D allele (p= 0.51) in a manner similar to nonselective beta1,2-blockers (p= 0.80). Treatment with beta1-blockers was sufficient to eliminate the adverse impact of the ACE D allele, suggesting this pharmacogenetic interaction is mediated through the beta1-receptor.
Details
- Title: Subtitle
- The beta1-adrenergic receptor mediates the pharmacogenetic interaction of the ACE D allele and beta-blockers
- Creators
- David C Ishizawar - Cardiovascular Institute, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania, USAKaren M JanoskoJeffrey J TeutebergLinda M CadaretMichael A MathierDennis M McNamara
- Resource Type
- Journal article
- Publication Details
- Clinical and translational science, Vol.1(2), pp.151-154
- DOI
- 10.1111/j.1752-8062.2008.00020.x
- PMID
- 20443839
- PMCID
- PMC5439562
- NLM abbreviation
- Clin Transl Sci
- eISSN
- 1752-8062
- Grant note
- K24 HL069912 / NHLBI NIH HHS K24 HL 69912 / NHLBI NIH HHS R01 HL75038 / NHLBI NIH HHS
- Language
- English
- Date published
- 09/2008
- Academic Unit
- Cardiovascular Medicine; Internal Medicine
- Record Identifier
- 9984094712902771
Metrics
9 Record Views